| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GPL24688
|
SRA Run Selector
|
|||||||
| GSM8346174 |
C1 biol rep 1
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346175 |
C2 biol rep 2
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346176 |
C3 biol rep 3
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346177 |
M1 biol rep 1
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346178 |
M2 biol rep 2
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346179 |
M3 biol rep 3
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346180 |
T1 biol rep 1
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346181 |
T2 biol rep 2
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8346182 |
T3 biol rep 3
|
SRA | 1 |
|
|
Xi Sun | Oct 09, 2024 | ||
| GSM8185746 |
PRVCMs treated with DMSO (Control), rep 1
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8185747 |
PRVCMs treated with DMSO (Control), rep 2
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8185748 |
PRVCMs treated with DMSO (Control), rep 3
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8185749 |
PRVCMs treated with ATRA 1, rep 1
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8185750 |
PRVCMs treated with ATRA 1, rep 2
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8185751 |
PRVCMs treated with ATRA 1, rep 3
|
SRA | 1 |
|
|
Shingo Narita | Aug 13, 2024 | ||
| GSM8255521 |
Nucleus pulposus cells from sham operation #1, RNA-seq
|
SRA | 1 |
|
|
Cao Yang | Jul 17, 2024 | ||
| GSM8255522 |
Nucleus pulposus cells from sham operation #2, RNA-seq
|
SRA | 1 |
|
|
Cao Yang | Jul 17, 2024 | ||
| GSM8255523 |
Nucleus pulposus cells from sham operation #3, RNA-seq
|
SRA | 1 |
|
|
Cao Yang | Jul 17, 2024 | ||
| GSM8255524 |
Nucleus pulposus cells from LSI #1, RNA-seq
|
SRA | 1 |
|
|
Cao Yang | Jul 17, 2024 | ||
| GSM8255525 |
Nucleus pulposus cells from LSI #2, RNA-seq
|
SRA | 1 |
|
|
Cao Yang | Jul 17, 2024 |
